TOI (STOCKS)
The Oncology Institute, Inc. Common Stock
$3.300000
+0.220000 (+7.14%)
Prev close: $3.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Daniel Virnich
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $324.69M
- Employees
- 825
- P/E (TTM)
- -5.86
- P/B (TTM)
- -20.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.06 | $-0.09 | +0.0309 | +33.99% |
|
Sep 2025 (Q3)
|
$-0.14 | $-0.11 | -0.0255 | -22.27% |
|
Jun 2025 (Q2)
|
$-0.15 | $-0.13 | -0.0187 | -14.24% |
|
Mar 2025 (Q1)
|
$-0.17 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $502.73M |
| Benefits Costs and Expenses | $563.47M |
| Costs And Expenses | $563.47M |
| Nonoperating Income/Loss | -$24.65M |
| Operating Expenses | $538.81M |
| Selling, General, and Administrative Expenses | $105.57M |
| Depreciation and Amortization | $6.94M |
| Other Operating Expenses | $426.29M |
| Operating Income/Loss | -$36.08M |
| Income/Loss From Continuing Operations After Tax | -$60.61M |
| Income/Loss From Continuing Operations Before Tax | -$60.74M |
| Income Tax Expense/Benefit | -$131.00K |
| Income Tax Expense/Benefit, Current | -$99.00K |
| Income Tax Expense/Benefit, Deferred | -$32.00K |
| Net Income/Loss | -$60.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$60.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$10.30M |
| Preferred Stock Dividends And Other Adjustments | -$10.30M |
| Basic Earnings Per Share | -$0.54 |
| Diluted Earnings Per Share | -$0.54 |
| Basic Average Shares | 92,389,381 |
| Diluted Average Shares | 92,389,381 |
| Assets | $164.66M |
| Current Assets | $112.75M |
| Inventory | $16.88M |
| Other Current Assets | $95.87M |
| Noncurrent Assets | $51.91M |
| Fixed Assets | $10.68M |
| Intangible Assets | $11.02M |
| Other Non-current Assets | $30.21M |
| Liabilities | $180.38M |
| Current Liabilities | $70.96M |
| Accounts Payable | $43.17M |
| Wages | $7.09M |
| Other Current Liabilities | $20.70M |
| Noncurrent Liabilities | $109.41M |
| Commitments and Contingencies | $0.00 |
| Equity | -$15.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$15.72M |
| Liabilities And Equity | $164.66M |
| Net Cash Flow From Operating Activities | -$24.59M |
| Net Cash Flow From Operating Activities, Continuing | -$24.59M |
| Net Cash Flow From Investing Activities | -$3.07M |
| Net Cash Flow From Investing Activities, Continuing | -$3.07M |
| Net Cash Flow From Financing Activities | $11.56M |
| Net Cash Flow From Financing Activities, Continuing | $11.56M |
| Net Cash Flow | -$16.10M |
| Net Cash Flow, Continuing | -$16.10M |
| Comprehensive Income/Loss | -$60.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$60.61M |
| Other Comprehensive Income/Loss | $0.00 |